Health economics

Real quick, one question I had for you before we get into the meat of the report.

I was looking-- we spoke last year to discuss the 2025 Trends Shaping the Health Economy Report, and I was looking between the two, and we didn't prep you on this, but I am kind of curious, like, when you're dealing with healthcare, which there are a lot of similar themes in the 2026 report versus the 2025 report, how do you think about trying to tell the story of the health economy from one year to the next?

Yeah.

It's an interesting task to do this report year over year, um, and try to put a new spin on things.

In some ways, the health economy moves somewhat slowly.

Uh, you know, the status quo, I think, is one of our biggest enemies within the healthcare system.

But I think the sort of overarching narrative, uh, a tragedy of the commons, that's sort of our focus of the 2026 trends report.

Uh, but our sort of thesis is that at some point, and we think that point is soon, there just aren't going to be enough healthcare dollars to sustain each of those parties' revenues, and that everyone's going to end up losing because of it.

They said that there was a shortage somehow or that it was pulled, but yeah, it went away.

There was a paper in Medical Economics that indicated that the US had purchased enough doses for every American to get monoclonal antibodies.

So they were existed.

And again, if I was running the show, every nursing home would have these stocked, every urgent care and hospital ER would have them stocked.